iHEA

International Health Economics Association

7th World Congress: Harmonizing Health and Economics

Advertisement: 7th World Congress: Harmonizing Health and Economics

« March 31, 2010 | Main | April 3, 2010 »

April 2, 2010

Research Scientist: Health Economics and Technology Assessment Mid America Heart Institute (MAHI), Saint Luke's Hospital

Location: Kansas City, Minnesota

The Division of Cardiovascular Research at the Mid America Heart Institute of Saint Luke’s Hospital in Kansas City has a long-standing national reputation in the field of cardiovascular quality of care and health outcomes research. The Health Economics and Technology Assessment group at MAHI is involved in the evaluation of the economic impact and cost-effectiveness of new therapies for the treatment of heart and vascular disease.

The position:

Provide hands-on health economics and outcomes research support for all phases of research for the Health Economics and Technology Assessment group at the Mid-America Heart Institute (MAHI). For clinical trial and registry-based health economic/cost-effectiveness studies sponsored by both public and private sector, lead and/or participate in study design and protocol and analysis plan development, and dissemination of results in the form of reports, abstracts and publications. Review and provide input into clinical trial protocols and case report forms from a health economic perspective. Provide leadership and direct research support for the development of economic models to assess and support cost-effectiveness using available clinical evidence and cost parameters; carry out background research on clinical cost data to populate models appropriately. Maintain current knowledge of economic methodologies in assessments for cardiovascular health practice and policy.

Required background/experience:

Masters degree required, doctorate preferred, in health economics, health services research,epidemiology, biostatistics, public health, or a related health field. Training in the conduct of cost-effectiveness studies, both model and trial-based, preferred. Advanced specialized training in econometric modeling a plus. Minimum 2+ years of professional experience in health economics and outcomes research, and strong quantitative, computational (e.g. TreeAge, SAS, Excel), and problem solving skills. Strong research design, methods, and data analysis skills. Excellent project management skills, with the ability to manage multiple projects simultaneously. Excellent interpersonal and team participation skills. Strong communication (verbal and written) skills. Demonstrated ability to independently and/or collaboratively conduct and manage health economic research projects. Clinical knowledge of cardiovascular disease preferred. Knowledge of regulatory, reimbursement and policy issues surrounding cardiovascular drugs and devices, a plus.

Interested applicants should send a cover letter and cv/resume to:

Elizabeth M. Mahoney,
Sc.D.Director, Health Economics and Technology Assessment
Mid America Heart Institute at Saint Luke’s Hospital
Associate Professor of Medicine, UMKC
4401 Wornall Road
Kansas City, MO 64111
emahoney1@saint-lukes.org

permalink April 2010: Epidemiologist , Health Economist , Researcher/Co-ordinator , Statistician

Senior Health Economist - Oncology

Location: Based SE England
Closing date for all applications: Friday 5th March

Boehringer Ingelheim is a privately-owned world-wide pharmaceutical corporation. Dedicated to researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life.

In the UK we were awarded 41st place in the Sunday Times Top 100 Best Companies to Work For 2009. We are very proud of this achievement and believe that it demonstrates our commitment to our employees

This is an excellent opportunity to join a prestigious global pharmaceutical company with a powerful and successful research base. Boehringer Ingelheim is currently expanding its Health Economics and Outcomes Research team and is seeking to appoint a Health Economist with proven experience to assist in the continued development of a pro-active in-house approach to the economic evaluation of its pharmaceutical products.

To join our team, you will ideally have an MSc in Health Economics (or a related, relevant qualification). You will have a good working knowledge of all methods of economic evaluation, as well as practical experience. We are seeking an ambitious and enthusiastic individual who should be expecting to manage their own portfolio from day 1. You will work closely with the Health Policy Manager (Oncology) and a second senior health economist (oncology) to develop and deliver the health economics and market access strategy for Boehringer Ingelheim’s oncology portfolio.

Your contribution to Boehringer Ingelheim’s programme will be rewarded with a competitive salary as well as the benefits package, career progression and training associated with a leading global pharmaceutical organisation.

Our employees are vital to our success and we aim to attract the best people who will stay and grow with us. We offer our employees opportunities to develop and advance their careers at both national and international level and we have created an environment that provides a good quality of life with a range of attractive benefits.

We are an equal opportunities employer.

If you wish to apply please visit http://www.bicareers.co.uk to apply online

permalink April 2010: Health Economist , Industry

Contact

iHEA 902-461-4432
902-461-IHEA

Tom GetzenExecutive Director and CEO

Bill SwanDeputy CEO